SLC35B4 and prostate cancer: Consistent with these observations, we found that increased SLC35B4 expression was associated with more aggressive forms of prostate cancer (Figure 4), and that silencing SLC35B4 markedly suppresses cancer cell proliferation, migration and invasion (Figure 3).